Search Results - "Vietti, Teresa J."

Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: a report from the Children's Oncology Group by Bhatia, Smita, Krailo, Mark D., Chen, Zhengjia, Burden, Laura, Askin, Frederic B., Dickman, Paul S., Grier, Holcombe E., Link, Michael P., Meyers, Paul A., Perlman, Elizabeth J., Rausen, Aaron R., Robison, Leslie L., Vietti, Teresa J., Miser, James S.

“…This study describes the magnitude of risk of therapy-related myelodysplasia and acute myeloid leukemia (t-MDS/AML) in 578 individuals diagnosed with Ewing…”
Get full text

Treatment of Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor of Bone: Evaluation of Combination Ifosfamide and Etoposide—A Children's Cancer Group and Pediatric Oncology Group Study by MISER, James S, KRAILO, Mark D, DONALDSON, Sarah S, MOORE, Sheila, RAUSEN, Aaron R, VIETTI, Teresa J, GRIER, Holcolmbe E, TARBELL, Nancy J, LINK, Michael P, FRYER, Christopher J. H, PRITCHARD, Douglas J, GEBHARDT, Mark C, DICKMAN, Paul S, PERLMAN, Elizabeth J, MEYERS, Paul A

“…One hundred twenty patients with metastatic Ewing's sarcoma or primitive neuroectodermal tumor (PNET) of bone were entered onto a randomized trial evaluating…”
Get full text

Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: Evaluation of increasing the dose intensity of chemotherapy-a report from the Children's Oncology Group by Miser, James S., Goldsby, Robert E., Chen, Zhengjia, Krailo, Mark D., Tarbell, Nancy J., Link, Michael P., Fryer, Christopher J.H., Pritchard, Douglas J., Gebhardt, Mark C., Dickman, Paul S., Perlman, Elizabeth J., Meyers, Paul A., Donaldson, Sarah S., Moore, Sheila G., Rausen, Aaron R., Vietti, Teresa J., Grier, Holcombe E.

“…Background The outcome for patients with Ewing sarcoma family of tumors (ESFTs) of bone with metastases at diagnosis remains poor despite new approaches to…”
Get full text

Addition of Ifosfamide and Etoposide to Standard Chemotherapy for Ewing's Sarcoma and Primitive Neuroectodermal Tumor of Bone by Grier, Holcombe E, Krailo, Mark D, Tarbell, Nancy J, Link, Michael P, Fryer, Christopher J.H, Pritchard, Douglas J, Gebhardt, Mark C, Dickman, Paul S, Perlman, Elizabeth J, Meyers, Paul A, Donaldson, Sarah S, Moore, Sheila, Rausen, Aaron R, Vietti, Teresa J, Miser, James S

“…Ewing's sarcoma, a highly malignant tumor of children, adolescents, and young adults, often responds to local excision plus a now-standard four-drug regimen of…”
Get full text

Cyclophosphamide Plus Topotecan in Children With Recurrent or Refractory Solid Tumors: A Pediatric Oncology Group Phase II Study by SAYLORS, Robert L, STINE, Kimo C, SULLIVAN, Jim, KEPNER, James L, WALL, Donna A, BERNSTEIN, Mark L, HARRIS, Michael B, HAYASHI, Robert, VIETTI, Teresa J

“…To determine the response rate of the combination of cyclophosphamide and topotecan in pediatric patients with recurrent or refractory malignant solid tumors…”
Get full text

Protracted Intermittent Schedule of Topotecan in Children With Refractory Acute Leukemia: A Pediatric Oncology Group Study by Furman, W. L.

Get full text

Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma by Haas, J E, Muczynski, K A, Krailo, M, Ablin, A, Land, V, Vietti, T J, Hammond, G D

“…To determine the relationship between outcome and histologic type, the authors examined data from 168 cases of hepatoblastoma (HB) and 28 cases of…”
Get more information

Ewing's sarcoma metastatic at diagnosis. Results and comparisons of two intergroup Ewing's sarcoma studies by Cangir, A, Vietti, T J, Gehan, E A, Burgert, Jr, E O, Thomas, P, Tefft, M, Nesbit, M E, Kissane, J, Pritchard, D

“…Two Pediatric Intergroup Ewing's Sarcoma studies of patients with metastatic disease (IESS-MD) have used multimodal therapy consisting of intensive combination…”
Get more information

The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity by Link, M P, Goorin, A M, Miser, A W, Green, A A, Pratt, C B, Belasco, J B, Pritchard, J, Malpas, J S, Baker, A R, Kirkpatrick, J A

“…We conducted a randomized controlled trial to determine whether intensive multi-agent adjuvant chemotherapy improves the chances of relapse-free survival in…”
Get more information

Protracted intermittent schedule of topotecan in children with refractory acute leukemia: A pediatric oncology group study by FURMAN, Wayne L, STEWART, Clinton F, PRATT, Charles, KIRSTEIN, Mark, KEPNER, James L, BERNSTEIN, Mark L, KUNG, Faith, VIETTI, Teresa J, STEUBER, C. Philip, BECTON, David Lee, BARUCHEL, Sylvain

“…To determine dose-limiting toxicity (DLT) and maximum-tolerated dose (MTD) of a protracted, intermittent schedule of daily 30-minute infusions of topotecan…”
Get full text

Low-Stage Medulloblastoma: Final Analysis of Trial Comparing Standard-Dose With Reduced-Dose Neuraxis Irradiation by THOMAS, P. R. M, DEUTSCH, M, MULHERN, R, STEHBENS, J. A, LANGSTON, J, STANLEY, P, DUFFNER, P, RORKE, L, CHERLOW, J, FRIEDMAN, H. S, FINLAY, J. L, VIETTI, T. J, KEPNER, J. L, KUN, L. E, BOYETT, J. M, KRISCHER, J, ARONIN, P, ALBRIGHT, L, ALLEN, J. C, PACKER, R. J, LINGGOOD, R

“…To evaluate prospectively the effects on survival, relapse-free survival, and patterns of relapse of reduced-dose (23.4 Gy in 13 fractions) compared with…”
Get full text

Phase I and clinical pharmacological study of mercaptopurine administered as a prolonged intravenous infusion by ZIMM, S, ETTINGER, L. J, POPLACK, D. G, HOLCENBERG, J. S, KAMEN, B. A, VIETTI, T. J, BELASCO, J, COGLIANO-SHUTTA, N, BALIS, F, LAVI, L. E, COLLINS, J. M

“…The bioavailability of oral mercaptopurine (MP) is poor, and plasma levels following p.o. dosing are highly variable. In an attempt to circumvent these…”
Get full text

The Third Intergroup Rhabdomyosarcoma Study by Crist, W, Gehan, E A, Ragab, A H, Dickman, P S, Donaldson, S S, Fryer, C, Hammond, D, Hays, D M, Herrmann, J, Heyn, R

“…The ultimate goal of the Third Intergroup Rhabdomyosarcoma Study (IRS-III, 1984 to 1991) was to improve treatment outcome in children with rhabdomyosarcoma…”
Get more information

The Intergroup Rhabdomyosarcoma Study-II by Maurer, H M, Gehan, E A, Beltangady, M, Crist, W, Dickman, P S, Donaldson, S S, Fryer, C, Hammond, D, Hays, D M, Herrmann, J

“…Intergroup Rhabdomyosarcoma Study (IRS)-II, (1978-1984) had the general goals of improving the survival and treatment of children with rhabdomyosarcoma (RMS)…”
Get more information

Osteoporotic fractures secondary to methotrexate therapy of acute leukemia in remission by Ragab, A H, Frech, R S, Vietti, T J

Get more information

Contrasting cytotoxicity kinetics of 5-azacytidine and dihydro-5-azacytidine hydrochloride in L1210 leukemia in mice by Presant, C A, Coulter, D, Valeriote, F, Vietti, T J

“…For a comparison of the kinetics of the cytotoxicity of dihydro-5-azacytidine hydrochloride (DHAzaCR) and 5-azacytidine (AzaCR) in L1210 leukemia, the spleen…”
Get more information

Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study by Nesbit, Jr, M E, Gehan, E A, Burgert, Jr, E O, Vietti, T J, Cangir, A, Tefft, M, Evans, R, Thomas, P, Askin, F B, Kissane, J M

“…A total of 342 previously untreated eligible children were entered into the first Intergroup Ewing's Sarcoma Study (IESS) between May 1973 and November 1978…”
Get more information

Acknowledgment of Reviewers by Vietti, Teresa J.

Get full text

Acknowledgment of Reviewers by Vietti, Teresa J.

Get full text

Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy : A report from the Intergroup rhabdomyosarcoma study Group by BREITFELD, Philip P, LYDEN, Elizabeth, RANEY, M. S. R. Beverly, TEOT, Lisa A, WHARAM, Moody, LOBE, Thom, CRIST, William M, MAURER, Harold M, DONALDSON, Sarah S, RUYMANN, Frederick B

“…This study was designed to estimate the partial and complete response rates (CR and PR) of two novel drug pairs (vincristine and melphalan vs. ifosfamide and…”
Get full text